Designer drugs to inhibit hepatitis A virus
Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection, according ...
Apr 30, 2019
0
29